The effect and safety of dexmedetomidine as an additive to ropivacaine for interscalene brachial plexus blocks for shoulder surgery.
Phase of Trial: Phase III
Latest Information Update: 01 Jan 2014
At a glance
- Drugs Dexmedetomidine (Primary) ; Ropivacaine (Primary)
- Indications Postoperative pain
- Focus Adverse reactions; Therapeutic Use
- 01 Nov 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 22 Mar 2012 Planned End Date changed to 12 Oct 2013.
- 22 Mar 2012 Planned initiation date changed from 12 Oct 2011 to NULL.